ESMO Clinical Practice Guideline interim update on new targeted therapies in the first-line and at relapse of chronic lymphocytic leukaemia
Cet article présente une mise à jour des recommandations de l'"European Society for Medical Oncology" concernant les nouvelles thérapies ciblées pour les leucémies lymphoïdes chroniques récidivantes ou non
The following ESMO Clinical Practice Guideline (CPG) has been recently updated with new treatment recommendations and updated algorithms for managing early and advanced disease: Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology , résumé, 2023